Northrop Grumman is rated as a 'HOLD' because its current valuation at 25 times earnings is too high compared to its modest 6-7% earnings growth and low dividend yield of 1.37%. The company faces sector challenges and risks from contract issues, while accounting methods add volatility and obscure financial health, especially with costly projects like the B-21 Raider. A price target of $450 per share suggests limited upside until valuation or growth improves significantly.
Northrop Grumman has started construction on a new building at its Roy Innovation Center in Utah to support the U.S. Air Force Sentinel Intercontinental Ballistic Missile program and other aerospace missions. This expansion will add to the existing c...
Small-cap stocks in the U.S. market continue to be the most undervalued segment, even after their best first-half performance in over 30 years, according to Morningstar's Q3 2026 outlook. The overall market shows a modest 8% discount to fair value, b...
